Brief: Senzime Is Approved For Listing On Nasdaq Stockholm
23/06/2021 14:36
June 23 (Reuters) - Senzime AB (publ) SEZI.ST :
* SENZIME HAS BEEN APPROVED FOR LISTING ON NASDAQ STOCKHOLM
* FIRST DAY OF TRADING ON NASDAQ STOCKHOLM'S MAIN MARKET IS
SCHEDULED FOR WEDNESDAY 30 JUNE 2021
Source text for Eikon: ID:nMFNs8GhM
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona